Canada markets closed

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7820-0.0360 (-4.40%)
At close: 04:00PM EDT
0.7859 +0.00 (+0.50%)
After hours: 07:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
15,529
15,529
13,907
4,359
0
Operating Expenses
Research Development
73,040
73,040
85,077
104,153
79,890
Selling General and Administrative
30,616
30,616
26,410
28,527
17,944
Total Operating Expenses
103,656
103,656
111,487
132,680
97,834
Operating Income or Loss
-88,127
-88,127
-97,580
-128,321
-97,834
Total Other Income/Expenses Net
-
-
-
-
-10,548
Income Before Tax
-86,884
-86,884
-95,940
-128,189
-108,382
Income Tax Expense
795
795
106
143
161
Income from Continuing Operations
-87,679
-87,679
-96,046
-128,332
-108,543
Net Income
-87,679
-87,679
-96,046
-128,332
-108,543
Net Income available to common shareholders
-87,679
-87,679
-96,046
-128,332
-108,543
Basic EPS
-1.89
-
-2.25
-3.22
-10.87
Diluted EPS
-1.89
-
-2.25
-3.22
-10.87
Basic Average Shares
43,117
-
42,695
39,855
9,988
Diluted Average Shares
43,117
-
42,695
39,855
9,988